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Background: Indian hedgehog (Ihh) signaling pathway is known to play key roles in various aspects of normal
endochondral bone development. This study tested the potential roles of high Ihh signaling in the context of
injury-induced bone regeneration.
Methods: A rabbit tibia defect model was established to test the effects of the implant of Ihh/mesenchymal stem
cells (MSCs)/scaffold complex. Computed tomography (CT), gross observation, and standard histological and
immunohistological techniques were used to evaluate the effectiveness of the treatment. In vitro studies with MSCs
and C3H10T1/2 cells were also employed to further understand the cellular and molecular mechanisms.
Results: We found that the implanted Ihh/MSCs/scaffold complex promoted bone repair. Consistently, in vitro study
found that Ihh induced the upregulation of chondrocytic, osteogenic, and vascular cell markers, both in C3H10T1/2
cells and MSCs.
Conclusions: Our study has demonstrated that high Ihh signaling in a complex with MSCs enhanced bone
regeneration effectively in a clinically relevant acute injury model. Even though the exact underlying mechanisms
are still far from clear, our primary data suggested that enhanced chondrogenesis, osteogenesis, and angiogenesis
of MSCs at least partially contribute to the process. This study not only has implications for basic research of MSCs
and Ihh signaling pathway but also points to the possibility of direct application of this specific paradigm to clinical
bone repair.
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Tissue engineeringIntroduction
Bone graft, such as autogenous iliac crest bone graft
(ICBG), is currently the most common approach for
bone defect repair [1], largely because of its impressive
osteoinductive, osteogenic, and osteoconductive abilities
[2,3]. However, this approach causes high morbidity
(~31%) of the iliac crest bone donors [4], which has sig-
nificantly limited its application in clinical settings. There-
fore, alternative approaches with the tissue-engineered
bone substitutes have been widely investigated. However,* Correspondence: l-kan@northwestern.edu; hongliang_hu67@hotmail.com
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unless otherwise stated.many common problems, such as the insufficient blood
supply of the tissue engineering bone [5] and the lack of
osteoinduction or osteogenesis capacity of polymeric scaf-
folds [6] still have not been adequately addressed.
Local application of certain factors, such as bone mor-
phogenetic proteins (BMPs) [7], fibroblast growth factors
(FGFs) [8], vascular endothelial growth factors (VEGFs),
RUNX2 in different contexts [9,10], and other bioactive
factors [11], and even systematic administration of anti-
body against sclerostin [12], have been proved to be
beneficial for bone repair. However, the effects of local
application of Indian hedgehog (Ihh) have not been sys-
tematically tested, even though it has been recently re-
ported that the activation of hedgehog signaling during
fracture repair enhanced osteoblastic-dependent matrix
formation [13].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vestigated largely as an important regulatory factor in
normal embryonic and neonatal bone development. In
this context, Ihh is thought to be a master regulator of
both chondrocyte and osteoblast differentiation, working
largely through regulatory feedback loops. In addition, Ihh
was also implicated in angiogenesis and vascularization of
newly formed bone [14,15].
Ihh receptors, both patched (Ptc,a conserved 12-
transmembrane protein) and smoothened (Smo, a 7-
transmembrane protein), are conserved. It is known that
secreted Hh proteins bind to receptor Ptc. The subse-
quent downstream signaling cascade, through receptor
Smo to the Ci or Gli1–3 transcription factors, can either
activate or inhibit specific target genes [16,17].
Furthermore, it is known that endogenous mesenchy-
mal stem/progenitor cells (MSCs) contribute to the
maintenance of healthy tissues or as immunomodulatory
sentinels. In consistent with this idea, MSCs from differ-
ent sources with a variety of modifications have also
been widely applied in regenerative medicines in differ-
ent clinical contexts [18,19]. These numerous studies
yielded promising yet often seemly conflicting data.
In this study, we specifically hypothesized that, similar
to what we have observed in normal embryonic and
neonatal bone development, Ihh signaling through ex-
ogenous MSCs might play a crucial role in the adult
bone remodeling and regeneration as well, likely work-
ing through promoting the chondrogenesis, osteogen-
esis, and angiogenesis of mesenchymal stem/progenitor
cells. Current study is designed to directly test this hy-
pothesis in vivo and in vitro. This study not only has
great implications for basic research of Ihh signaling
pathway and MSCs but also suggested the possible dir-




Fifty New Zealand white rabbits (8-weeks old, about
1.5–2.0 kg each) were purchased from Shanghai labora-
tory animal farm (animal quality number: SCXK Shanghai
2007-0008). All animal experiments were approved
and performed in an animal core facility at the Shanghai
Institute of Planned Parenthood Research (SIPPR).
Constructs, transfection and retroviral generation
The flag-tagged human Ihh cDNA, a kind gift from Dr.
Gang Ma (Bio-X center, Shanghai Jiao Tong University),
was subcloned into the HindIII and EcoRV sites of pCIG-
enhanced green fluorescence protein (EGFP), which con-
tains also the EGFP, the internal ribosomal entry site (IRES),
and the nuclear localization signal (NLS) sequences for
EGFP. The pSFG-EGFP-Ihh (Additional file 1: Figure S1A)and pSFG-EGFP retroviral constructs were subcloned in
the similar way and confirmed by DNA sequencing, EGFP+
Ihh+ viruses and EGFP+ viruses were packaged in 293GPG
cells as previously described [20]. C3H10T1/2 cells and
rabbit bone marrow mesenchymal stem cells were infected
with viruses at about 80% confluence in medium supple-
mented with 8 g/L polybrene for 24 h.
Cell culture
The C3H10T1/2 cells, the murine mesenchymal stem
cells line, were purchased from ATCC (Manassas, VA,
USA). 293GPG cells were from the Department of Medi-
cine, Washington University Medical School. Bone mar-
row MSCs were extracted from femurs and tibias of 2-
month-old healthy New Zealand white rabbits. Briefly,
the femurs and tibias were first flushed with PBS and
disinfected with 70% alcohol sprinkling, and then the
bone marrow aspirates were obtained in laminar flow
hood with a syringe filled with 2-ml MSC culture
medium. MSCs were then isolated by centrifuging for 20
min in 1.073 g/ml Ficoll gradients at 1,000 r/min and
then seeded at a density of 1 × 106 cells per 10-cm petri
dish in MSC culture medium. After 72 h, the medium
was changed to remove non-adherent cells. At 90% con-
fluence, the adherent cells were split at a ratio of 1:3 (p1,
passage 1). Passage 3 (p3) of MSCs were routinely used
in this study.
Chondrogenic differentiation: chondrogenesis was in-
duced in monolayer in chondrogenic media (CDM1).
CDM1 is high-glucose Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 100 ng/ml of
BMP2 (R&D Systems Inc. Minneapolis, MN, USA), 10
ng/ml of transforming growth factor-β3, 100-nM dexa-
methasone, 50 μg/ml of L-ascorbic acid 2-phosphate,
100 μg/ml of pyruvate (Sigma-Aldrich, St. Louis, MO,
USA), 40 μg/ml of proline (Sigma-Aldrich), and 10 μl/ml
of ITS+ (BD Biosciences, San Jose, CA, USA). Three
weeks after induction, cultures were divided into two
groups, i.e. in group I, the cells were fixed and stained
with 1% Alcian Blue to detect matrix deposition of sul-
fated glycosaminoglycans (GAGs), and in group II, cells
were lysed to extract total RNA, which were used to
generate cDNA to probe the transcriptional profile of
these cells.
Osteogenic differentiation: osteogenesis was induced
by osteogenic differentiation media (ODM1), which con-
sists of low-glucose DMEM supplemented with 10%
fetal bovine serum (FBS), 100-nM dexamethasone, 10-
mM β-glycerophosphate, and 50-μl M L-ascorbic acid
2-phosphate. On day 21 of cultivation in osteogenic
medium, cells were fixed and stained either with BCIP/
NBT kit to detect alkaline phosphatase (ALP) or 1% ali-
zarin red S to detect calcified extracellular matrix.
Some cells were also lysed to extract total RNA, which
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tional profile of these cells.
ALP, Alcian Blue, and alizarin red staining
Cover slides were fixed in 95% alcohol, and ALP staining
was performed with BCIP/NBT kits, according to the man-
ufacturers’ protocols (Beyotime Institute of Biotechnology,
Jiangsu, China). The production of GAGs was determined
by Alcian Blue staining (Sigma-Aldrich, St. Louis, MO,
USA), according to standard protocol. Alizarin red staining
was performed according to standard protocol. Briefly,
slides were stained with the alizarin red solution for 30 s to
5 min and the reaction was observed microscopically. Ex-
cess dye was shaken off, and the sections were dehydrated
in acetone, 20 dips, and then in acetone-xylene (1:1) solu-
tion, 20 dips. Sections were cleaned in xylene and mounted
with a synthetic mounting medium.
Immunostaining
For immunohistochemistry, cells were plated on gelati-
nized cover slips in 35-mm petri dish. At about 90%–
100% confluence, cell on cover slips were washed, fixed,
blocked, and then primary antibody was added and incu-
bated for 12 h at 4°C. After the washes, the secondary
antibody was added at 37°C for 1 h. The stained sections
were examined and imagined under confocal (Leica
Microsystems GmbH, Mannheim, Germany) or optical
microscopy (Olympus Optical Co. Ltd, Tokyo, Japan).
3-(4,5)-dimethylthiahiazo (-z-y1)-3,
5-di-phenytetrazoliumromide (MTT) assay
The cells/HA complexes of the three groups were cul-
tured in 800 μl growth medium on 24-well plates. Five
percent MTT was added aseptically to each wells and in-
cubated for 4 h. After the incubation, culture medium
was removed, and dimethyl sulfoxide was added. The ab-
sorbance (OD) was measured at the wavelength of 570
nm, and the data were analyzed with the software package
SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
Real-time (RT)-PCR
Total RNA were extracted according to manufacturer’s
instructions. cDNA was synthesized with GoScript™
Reverse Transcription System (Promega Biotech Co.,
San Luis Obispo, CA, USA). RT-PCR was carried out in
GeneAmp PCR System 9700 (Applied Biosystems, Foster
City, CA, USA). Three independent experiments were
performed for each sample with β-actin as internal con-
trol. Qualitative PCR (qPCR) assay was performed with
SYBR Green master mix (Life Technologies Corporation,
Carlsbad, California, USA), as recommended (Applied
Biosystems, Foster City, CA, USA), with GAPDH as an in-
ternal control.The seeding of hydroxyapatite scaffolds
Hydroxyapatite (HA) composite material (Yihuajian
Science and Trade Co., Ltd, Beijing, China), batch num-
ber 100518, serial number 100518 f704, specifications
45 × 45 × 1.8 mm. The HA scaffolds were cut into 3.5 ×
3.5 × 1.8 mm pieces for the current study. P3 rabbit MSCs
were divided into three groups to be infected by different
viruses (either EGFP+ Ihh+ virus, or EGFP+ virus, or no
virus control). Infected cells were then harvested, and 1 ×
107 infected cells were then seeded into each HA scaffold.
Seeded HA scaffolds were subsequently cultured for four
more days, with daily growth medium replacement. The
growth and stent of cells on HA scaffold’s surface was
measured by fluorescence microscope and scanning elec-
tron microscopy (SEM; Philips Quanta-200, FEI Com-
pany, Netherlands). At least 80% of the available inner
surface of HA scaffolds was covered by seeded cells at the
time of implantation.
For SEM observation, the cells/HA complexes were
fixed in solutions of 2.0% glutaraldehyde and 1.0% osmic
acid. Dehydration of the fixed samples was conducted
with acetone and isoamyl acetate, and then the dehy-
drated cells/HA complexes were coated in vacuum be-
fore the scanning.
Rabbit tibia defect model, the implantation and CT
analysis
Tibia defect model was established similar to previous
reports [21-23]. Briefly, animals were anesthetized first,
and then tibia platforms of hind limbs were exposed,
and defects were made on tibial plateau with a 5-mm
diameter circular drill bit close to the growth plate.
The periosteum and the underlying bony tissue were re-
moved sequentially by the drilling, and the depth of de-
fect is about 2.0 mm, which is less than the thickness of
the adjacent cortical bone (Additional file 2: Figure S2).
Since this model reflects the features of both the tibial
plateau defect and the cortical drill hole defect in the
proximal tibia, it was called the tibial plateau defect
throughout the paper. Forty New Zealand white rabbits
(12-weeks old) were randomly divided into two groups,
A and B. Rabbits in group A received EGFP+ Ihh+
MSCs/HA (left side) and EGFP+MSCs/HA (right side),
and the group B rabbits received MSCs/HA only (left or
right side, randomly).
The shape and the size of the tibia defect (the burr
hole) and the implant (cells/HA complexes) were opti-
mized based on our primary study, which found that a
drill (circle, 5 mm in diameter) was able to produce a
more consistent defect, while a cubical scaffold (3.5 ×
3.5 × 1.8 mm) could be generated more consistently. In
this paradigm, the cubical scaffold (3.5 × 3.5 × 1.8 mm)
can be easily fitted into a burr hole (5 mm in diameter ×
2 mm), since the diagonal of the square is largely the
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and the height of the implant is close to the depth of the
burr hole (1.8 vs 2 mm) (see Additional file 2: Figure S2
for details). The scaffold was secured into the defect by
suturing the surrounding soft tissue and skin separately
after implantation.
After implantation, postoperative activity, diet, survival
condition, complications, and wound healing time were
recorded daily. For evaluation of bone formation in the
defect sites, computed tomography (CT; Siemens PET—
CT 120 kV, 45 mA) scan was performed on the rabbit
tibia at four different time points, i.e., 2, 4, 8, and 12
weeks after surgery.
Gross and histological evaluation of bone regeneration
Animals were sacrificed at 4 and 12 weeks after implant-
ation, and the tibia platforms of hind limbs were ex-
posed and photographed for further analysis. Harvested
tissue from the bone defect sites were fixed in 4% PFA
immediately, decalcified in 10% EDTA, and embedded in
OCT. Frozen sections were used for histological andFigure 1 Overexpression of Ihh in C3H10T1/2 up-regulates Gli2 and G
overexpression of Ihh (GFP+, green) co-localized with upregulated Gli2 and
cells, and the second and fourth rows were transfected cells. The first three
(red), respectively, and the fourth column is the merged images of the resp
Gli3 and GFP, were in the nuclei (DAPI+, blue). Scale bars = 5 μm.immunohistochemistrical studies, according to standard
protocols.
Results
Evaluation of the Ihh overexpression in MSCs and
C3H10T1/2 cells
We first confirmed that the construct indeed overex-
pressed Ihh protein in C3H10T1/2 cells, through epi-
fluorescence microscopic imaging and Western blotting
(Additional file 1: Figure S1). Furthermore, high level of
Hh target genes, Gli2 and Gli3, were detected in the nu-
clei of EGFP+ Ihh+ C3H10T1/2 but not in the control
cells (Figure 1), strongly suggesting that Ihh overexpres-
sion construct worked as we expected.
We next examined the effects of overexpression of Ihh
in MSCs and C3H10T1/2 cells, using retrovirus vector
pSFG, which usually has higher and more consistent in-
fection efficiency than plasmid construct. The isolated
MSCs contained various cells from the bone marrow,
but majority of the attached cells are long, slender, and
spindle-like shape after splitting (data not shown).li3 in the nuclei. Typical images of double staining demonstrated
Gli3 (red), respectively. The first and third rows were none transfected
columns are the split channels of DAPI (blue), GFP (green), Gli signals
ective three split channels. Note that the most signals, both Gli2 and
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scaffolds
To directly test whether Ihh overexpressing MSCs can
proliferate and survive in HA scaffolds in vitro, a pre-
requisite for the subsequent implantation, we seeded the
viral (EGFP+ or EGFP+ Ihh+) infected or control MSCs
into HA scaffolds. Two days after seeding, healthy cells
were observed both on the outer and internal surfaces of
scaffolds in all three groups. On day 7, the surface of
HA scaffolds are almost completely covered with tightly
arrayed GFP+ cells (Additional file 3: Figure S3A), and
more importantly, no obvious difference of cell density
was observed in different groups (data not shown). SEM
further confirmed that cells with a typical spindle-like shape
were attached to HA scaffold (Additional file 3: Figure S3B).
To directly monitor the cell viability on scaffolds,
MTT assay was performed. Table 1 summarized the vi-
able cell in different groups at different time points.
These data indicate that overexpression of Ihh in MSCs
did not obviously change the cell proliferation or cell
survival on the surface of HA scaffolds.
Establishment and evaluation of rabbit tibia defect model
Numerous bone defect models in different species with
different defect size and on different sites have been re-
ported in literatures [21]. We established a tibia defect
model in rabbit in our current study similar to previous
reports [22,23], mainly because not only tibial defect re-
mains one of the major bone defects in clinic but also this
model is relatively easy and straightforward with high re-
peatability. The shape and the size of the defect (the burr
hole) and the implant (cells/HA complexes) were opti-
mized based on our primary study (see Additional file 2:
Figure S2 and ‘Materials and methods’ section for details)
to minimize the intra- and inter-group variations.
The complications of surgery, such as superficial or
deep infection, hematoma, and bone fracture, were
rarely observed in this model (only 1/40 animals had an
accidental tibia fracture). Normally, within 3–4 days
after surgery, rabbits showed slightly reduced appetite
and activities with a little difficulty to move around. But
these adversary effects were diminished at about 1 week
after surgery, and no obvious intra- or inter-group be-
havioral difference was observed at any time point (data
not shown). CT scanning confirmed that bone defectTable 1 The effects of EGFP or Ihh gene on the proliferation o
Time
Day 1 Day
BMSCs-HA 0.223 ± 0.007 0.27
EGFP+ BMSCs-HA 0.223 ± 0.013 0.26
EGFP+Ihh+ BMSCs-HA 0.225 ± 0.009 0.25
MTT results presented as OD values of three independent experiments.can be created in the plateau zone of all rabbit tibias
consistently (Figure 2 and data not shown). The unique
shape, anatomic location, and optic density on the CT
imaging can also easily distinguish the newly generated
bone with endogenous intact bone and the cells/HA
complexes.
Histological studies confirmed that the implanted cells
survived in the long-term
To help to understand the model and interpret the final
results, we implanted Ihh/MSCs/scaffold complex (EGFP+
Ihh+ MSCs/HA), in parallel with two control groups
(EGFP+ MSCs/HA or MSCs/HA), into an established
bone defect model. Histological studies at different time
points were performed to directly test whether implanted
cells survive in long-term in vivo to exert the desired ef-
fects. Interestingly, unlike some report, we found that
EGFP+ cells were persistently present in the injury site
and the newly regenerated bony callus as late as 12 weeks
after implantation. More importantly, many EGFP+ cells
in both control and case group were integrated into newly
generated bone at the time (12 weeks) of most biodegrad-
able scaffold no longer visible (Figure 3). This data must
be taken into consideration into the final interpretation of
the data.
CT scanning and gross observation suggested that
implanted Ihh/MSCs/scaffold complex strongly promoted
bone repair
The effectiveness of implanted Ihh/MSCs/scaffold complex
was evaluated first with CT scanning images. Fortunately,
the newly generated bone could be easily distinguished
from the endogenous intact bone and MSCs/HA com-
plexes by the specific anatomic location and typical vari-
able density on the CT imaging (Figure 2).
Specifically, we found that, at 2 weeks after implant-
ation, CT scanning showed no obvious bone regeneration
in any groups, and each MSCs/HA complex were clearly
visible as a separate optical dense object in the burr hole.
At 4 weeks, the EGFP+ Ihh+ MSCs/HA group showed
new bone formation, with mildly enhanced bone density
at the inner edge, and this new bone formation was not
apparent in control groups (EGFP+ MSCs/HA and
MSCs/HA groups), and the MSCs/HA complexes were
still clearly visible without obvious inter-group variation.f BMSCs in HA
2 Day 3 Day 4
1 ± 0.005 0.352 ± 0.041 0.574 ± 0.017
7 ± 0.016 0.353 ± 0.011 0.573 ± 0.043
4 ± 0.012 0.310 ± 0.029 0.447 ± 0.021
Figure 2 CT images demonstrated that Ihh+MSCs/hydroxyapatite complex promoted bone regeneration in tibia defect model.
(a-l) Typical CT images at different time points strongly suggested that only Ihh+ MSCs/hydroxyapatite complex (c, f, i, and l) promotes bone
regeneration, comparing to MSCs/hydroxyapatite complex (a, d, g, and j), or EGFP+MSCs/hydroxyapatite complex (b, e, h, and k). At 2 weeks
after implantation, no obvious bone regeneration was observed in any group (a-c). At 4 to 8 weeks, significantly more newly formed trabeculae
were observed at the inner edges of defect sites in the Ihh+ EGFP+ MSCs/HA group (f and i), comparing to control groups (d, e, g, and h). At 12
weeks, the tibia defects were completely filled with new bone (l), while defects persistent in control groups (j and k). Note that, at the early time
points (2 to 8 weeks), the cells/HA complexes can be easily identified by their unique shape and the anatomic location. In all panels, the newly
generated bone could also be easily distinguished from the endogenous intact bone and cells/HA complexes by the anatomic location and
variable density on the CT imaging. (m) The quantification of the volumes of the newly formed bone in each group (the volumes of cells/HA
complexes, if there was any, were not counted as newly formed bone) (a-l). Note that the volumes of the newly regenerated bone were significantly
higher in the group treated with Ihh+ MSCs/hydroxyapatite composites from 4 weeks after implantation onward. White arrows in (a-l) point to injury
sites. Errors bars, SD, *p< 0.05 (n = 5, paired t-test).
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Figure 3 The long-term survival of the implanted cells was confirmed by histological studies. Histological studies were performed at
different time points, i.e., 4, 8, and 12 weeks (showed) after implantation, to directly test whether EGFP+ were persistently present in injury site.
Typical images of newly regenerated bony callus in adjacent to the endogenous bone from different groups (top row, EGFP+ Ihh+ MSCs; middle
row, EGFP+ MSCs; bottom row, control MSCs only) are shown. Note that many EGFP+ cells (either with or without Ihh overexpression) were not
only survived but also apparently integrated into newly generated bone in both EGFP+ Ihh+ MSCs and EGFP+ MSCs groups. Overall, the first column is
the phase images, the second column is the florescence images of GFP, and the third column is the merged images. Scale bars = 50 μm.
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bone tissue can be observed at the defect area in EGFP+
Ihh+ MSCs/HA group, while discontinuously trabecular
bone tissues were also observed in the control groups at
this time point. The MSCs/HA complexes were still vis-
ible at this time point, but the optical density seemed to
be decreased in all groups without obvious inter-group
variation.
Interestingly, at 12 weeks, completely healed tibia de-
fects were observed in five out of five rabbits in the
EGFP+ Ihh+ MSCs/HA group (Figure 2). In contrast, this
was observed in none of rabbits in control groups, even
though variable degree of healing was indeed observed
in both control groups. Furthermore, the unique signal
of MSCs/HA complexes were almost completely disap-
peared at this time point (12 weeks) from all groups,
which was not a surprising finding considering the bio-
degradability of HA complexes. Interestingly, we alsonoticed that the thickness of newly formed bony callus
was similar to that of normal tibia (Figure 2a-l).
We quantified the volume of newly formed bone in each
groups based on CT scanning, and we found an significant
increase in bone regeneration in the EGFP+ Ihh+ MSCs/
HA group from week 4 onward (n = 5, p< 0.05, Figure 2m).
These findings strongly suggested that EGFP+ Ihh+ MSCs/
HA constructs enhanced bone repair.
However, it is well known that CT scanning is sensitive
to detect the mature bony regeneration, not the early
phases of the process, such as chondrogenesis and the
vasculation, thus, we reasoned that it is possible that CT
scanning might fail to detect the early effects of EGFP+
Ihh+ MSCs/HA. To circumvent this limitation, we re-
opened the injury sites at different time points and
grossly observed the potential regeneration. At two
weeks after implantation, no significant intergroup dif-
ference was found. However, unlike CT imaging, gross
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early as 4 weeks after implantation. Specifically, we
found that the newly formed cartilage and well-arranged
capillary network were visible in the injuries sites and
surrounding area in the EGFP+ Ihh+ MSCs/HA group
but not in control groups (Additional file 4: Figure S4).
More importantly, similar to CT scanning, this inter-
group difference was persistent, i.e., complete healing was
only observed in EGFP+ Ihh+ MSCs/HA group, at 12
weeks after implantation not in control groups (Figure 4).
Overall, as expected, the only obvious difference is that
the gross observation is more sensitive to detect the
changes in the early healing process. Together, these ob-
servations suggested that implanted Ihh/cell/scaffold
complex promoted bone repair. However, the observed
relatively late effects raised the possibility that Ihh/
MSCs/scaffold complex worked through indirect mecha-
nisms, even though gross observation suggested that en-
hanced chondrogenesis, osteogenesis, and angiogenesis/
vasculation might play key roles in this process.
Enhanced osteogenesis and angiogenesis in EGFP+ Ihh+
MSCs/HA implanted group
We next performed histological study to further under-
stand how EGFP+ Ihh+ MSCs/HA implants promote
bone repair in this model. Specifically, at 4 weeks follow-
ing implantation, histological study found that there
were many cells inside the microchannels and around
the HA scaffolds in all three groups. Even though the
total cell density seemed not significantly different
among three different groups, obvious bony callus were
only found around the implants in EGFP+ Ihh+ MSCs/
HA group, suggesting enhanced osteogenesis in this
group (Figure 5). Similar trend was also observed in later
time points (data not shown). Together, histological
study, gross observation, and CT scanning all suggested
the increased chondrogenesis, osteogenesis, and angio-
genesis only in EGFP+ Ihh+ MSCs/HA group.
However, due to the long course of healing and the
complicate in vivo microenvironment, we reasoned that
it is beyond the scope of this study to fully delineate theFigure 4 Macroscopic observations further strengthened the idea tha
At 12 weeks after the implantation, complete bone union was observed in
defects were persistent in control groups (a and b). Arrows in all panels po
undetectable in any group at this time point.exact sequence of the events in vivo. Furthermore, lack
of high affinity rabbit lineage specific antibodies also
limited us to directly observe the potential osteogenic,
chondrogenic, or angiogenic fate changes of the donor
cells in vivo.
In vitro study not only strengthened the idea that high
Ihh signaling could promote chondrogenesis,
angiogenesis, and osteogenesis but also revealed
potential feedback Ihh signaling regulation
For abovementioned reasons, we next turned our attention
to more controlled in vitro experiments to further under-
stand the underlying cellular and molecular mechanisms.
Consistent with the in vivo studies, we found that overex-
pression of Ihh in C3H10T1/2 or MSCs cells led to high
level of Alcian Blue staining (Figure 6a–d). ALP staining
also demonstrated that Ihh induced an elevated ALP ex-
pression in MSCs (Figure 6e–f). Consistently, in vitro IHC
study also found that Ihh-transfected C3H10T1/2 cells
showed upregulated expression of osteocalcin (Oc, a
marker of the mature osteoblasts) and CD31 (an endothe-
lial cell marker), 21 days after gene transfection (Additional
file 5: Figure S5). More interestingly, higher expression of
CD31 or Oc is not consistently co-localized with GFP,
which might suggest that Ihh signaling could work through
non-cell-autonomous mechanisms.
In addition, RT-qPCR (Figure 7) and RT-PCR (Additional
file 6: Figure S6) were used to further probe the underlying
molecular mechanisms and the Ihh signaling regula-
tion. By RT-qPCR, we found that Ihh not only induced
the upregulation of molecular markers of angiogenic
factor (VEGF), angiogenic marker (CD31), and osteo-
genesis (ALP) but also induced factors that might poten-
tially feedback regulate the Ihh signaling regulation (Ptc1,
Smo, and PTHrP) in C3H10T1/2 cells (Figure 7). The
general regulated expression patterns were repeated in an-
other set of RT-PCR (Additional file 6: Figure S6).
Discussion
Numerous previous reports indicated that Ihh signaling
not only controls chondrocyte and osteoblast developmentt Ihh+MSCs/hydroxyapatite complex promote bone regeneration.
group implanted with EGFP+ Ihh+ MSCs/HA constructs (c), while bone
ints to the injury sites. Note that the hydroxyapatite complex was
Figure 5 Histological study found enhanced osteogenesis and angiogenesis in Ihh+MSCs/hydroxyapatite group. Typical images at 4
weeks after implantation of MSCs/hydroxyapatite complex (a and a′), EGFP+ MSCs/hydroxyapatite complex (b and b′), and EGFP+Ihh+ MSCs/
hydroxyapatite complex (c and c′) show the histological features adjacent to the implantation sites in different groups. Low power images are
shown in (a), (b), and (c), and (a′), (b′), (c′) are the higher power images of boxed area from (a), (b), and (c), respectively. Note that only (c) and
(c′) shows the typical histological features of newly formed trabeculae and nascent angiogenesis. Scale bars = 100 μm.
Figure 6 Ihh promotes the expression of chondrogenic and osteogenic markers in vitro. Both C3H10T1/2 cells (a and b) and rabbit MSCs
(c-f) were used in this study. Typical images demonstrated that under chondrogenic condition (a-d), strong Alcian Blue staining was observed in
both EGFP+ Ihh+ C3H10T1/2 cells (b) and EGFP+ Ihh+ MSCs (d) 21 days after transfection, while only minimum Alcian Blue staining was observed
in control groups (a and c). Similarly, under osteogenic condition (e and f), strong ALP+ staining was observed only in EGFP+ Ihh+ MSCs (f) not
in MSCs group (e), 7 days after transfection. Scale bars = 100 μm.
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Figure 7 Ihh differentially regulates the expression of markers of osteogenic, chondrogenic, angiogenic, and Ihh signaling genes.
Consistent with the previous study, the expression of the earliest osteogenic marker gene, ALP, was almost always upregulated (a). Similarly,
angiogenic factor (VEGF) and markers (CD31) were also mostly upregulated (c and d). Strangely, for unknown reasons, Col2a1 a chondrogenic
marker was only marginally regulated by Ihh in C3H10T1/2 cells (b). Ptc1 and Smo, Ihh receptors, are upregulated by Ihh at most time points
(e and f). In contrast, the expression of PTHrP, a factor in the negative feedback loop of Ihh signaling, was unchanged or suppressed at some
time points in C3H10T1/2 cells (g). *p< 0.05, statistical significance (paired t-test, comparing with control group at the same time point).
Zou et al. Journal of Orthopaedic Surgery and Research 2014, 9:102 Page 10 of 13
http://www.josr-online.com/content/9/1/102but also promotes cartilage vascularization [14,15], in the
normal physiological process of endochondral bone forma-
tion. For example, Vortkamp lab [24] has shown that Ihh
and PTHrP are secreted by prehypertrophic chondrocytes
and then have an effect on neighboring or distant cells
(through non-cell autonomous mechanisms). The feedback
loop of Ihh/PTHrP co-regulates the proper development of
cartilage tissue and promote vascular invasion in theprehypertrophic stage [25], at least partially through syn-
chronizing and determining the pace of differentiation of
chondrocytes and osteoblasts in the growth plate [9,14].
In acute injury context, previous data also indicate that
Ihh is expressed in chondrocytes and osteoblasts during
the process of fracture healing in adult rat femora [26],
consistently, the activation of hedgehog signaling during
fracture repair enhances osteoblastic-dependent matrix
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http://www.josr-online.com/content/9/1/102formation [13]. These data all suggested that Ihh might
also play a role in the regulation of bone repair or re-
modeling in adult animals. Additional study in the re-
generating deer antler further suggested that molecules
which regulate embryonic skeletal development and
postnatal epiphyseal growth, including Ihh, may also
control blastema formation, chondrogenesis, and bone
formation. However, no investigator has specifically
tested whether and how high Ihh signaling could regu-
late adult bone regeneration after acute injury in a clin-
ically relevant model.
To the best of our knowledge, this is the first study
that directly tested the functional consequences of local
application of high Ihh signaling through MSCs in a
clinically relevant context. In this proof-of-concept
study, we generated MSCs/scaffold complex using MSCs
transfected with EGFP+ Ihh+ viruses and implant this
construct into an in vivo model of rabbit tibia defect.
Our results of CT imaging and gross and histological
observations revealed that implanted EGFP+ Ihh+ MSCs/
HA constructs significantly accelerated the bone regen-
eration. This finding indicated that high Ihh signaling
could promote adult bone regeneration after acute in-
jury. This conclusion has been well supported by our
data and is of great interest.
However, to extensively delineate the exact sequence of
the cellular or molecular events or prove the causal rela-
tionship in vivo or in vitro is far beyond the scope of this
study, nevertheless, our current in vitro and in vivo studies
did suggest that enhanced chondrogenesis, osteogenesis,
and angiogenesis might be all involved in the relatively
long healing process. Our double-staining and other data
further suggested that Ihh could work through non-cell-
autonomous mechanism, however, the possibility of cell-
autonomous effects can not completely excluded by our
current data. For this reason, more detailed future studies
will be needed to further clarifying the underlying molecu-
lar mechanisms.
It is worthy to mention that even though it is known
that endogenous mesenchymal stem/progenitor cells
contribute to the maintenance of healthy tissues or as
immunomodulatory sentinels, and MSCs from different
sources with a variety of modifications have also been
widely applied in regenerative medicines in different
clinical contexts [18,19], control MSCs without Ihh over-
expression were far less efficient in promoting the bone
healing process, comparing to MSCs with Ihh overex-
pression in our study.
An obvious limitation of our current study is that this
study did not have a sham surgery group that did not re-
ceive the MSCs. For this reason, we could not tell for
sure whether MSCs alone have any pro-healing activity.
Another limitation is that, in our in vitro study, unlike
the commonly accepted in vivo finding, overexpressionof Ihh in C3H10T1/2 cells was unable to induce the
PTHrP gene (Figure 7), which may reflect the absence of
specific microenvironmental factors in vitro [27], alter-
natively, the induction of PTHrP was failed to be de-
tected simply because the induction was transient or
happened only in an insignificant small subpopulation. It
is also interesting to notice that the mRNA levels of
BMP2 and BMP4 were not significantly changed in our
in vitro study either, even though Duench and Franz-
Odendaal reported that BMPs might be direct targets of
Ihh signaling [28]. Other limitations of our current stud-
ies are the following: 1) the size of rabbit tibial plateau
precluded the possibility to establish a bigger defect,
which might be more sensitive in detecting the pro-
healing effects of implant,and 2) the safety issue of retro-
viral system excluded the possibility of direct clinical ap-
plication of our system.
Nevertheless, the implications of this study are at least
twofold: for the basic study of Ihh signaling, we reason
that this study may provide a valuable framework and
foundation to further delineate the potential underlying
molecular and cellular mechanisms, and this working
model may be even useful for studying the crosstalking
of Ihh signaling with other key signaling pathways such
as Wnts, BMPs, and other growth factors. For the clin-
ical front, the similar approach could potentially apply
to clinical treatment of acute bone defect, if the safety
concern of the viral delivery system has been appropri-
ately addressed.Conclusions
In summary, we found that implanted Ihh+ MSCs/hy-
droxyapatite enhanced bone regeneration effectively in a
clinically relevant acute injury model. Even though the
exact underlying mechanisms are still far from clear, our
primary data suggested that enhanced chondrogenesis,
osteogenesis, and angiogenesis of mesenchymal stem/
progenitor cells could at least partially contribute to the
healing process. This study not only has implications for
basic research of Ihh signaling pathway but also points
to the possibility of direct application of this specific
paradigm to clinical bone repair.Additional files
Additional file 1: Figure S1. Map and the evaluation of Ihh
overexpression plasmid. (A) Map of pSFG-EGFP-Ihh. (B) C3H10T1/2 cells
infected with retrovirus expressed GFP. (C) Expression of Ihh protein was
evaluated by Western blotting. By staining with flag antibody, a specific
46 kDa band was detected only in Ihh transfected C3H10T1/2 cells. Cont,
C3H10T1/2 cells transfected with EGFP gene; Ihh, C3H10T1/2 cells
transfected with EGFP and Ihh genes. Scale bars = 250 μm.
Additional file 2: Figure S2. Schematic views of implantation of
cells/HA complex into bone defects. (a) Rabbit tibia defect model.
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http://www.josr-online.com/content/9/1/102(b)Schematic view of the size of HA scaffold and burr hole in rabbit tibia
defect model. Note that HA scaffold was well-fitted in the burr hole.
Additional file 3: Figure S3. Observation of EGFP+Ihh+MSCs inside HA
complex. (A) Tightly arrayed GFP+ cells were observed inside HA complex
under inverted fluorescence microscope. (B) Representative SEM picture
showed that the typical spindle-like shape cells were attached to HA scaffolds.
(A) and (B) essentially confirmed that the seeded cells survived on the surface
of HA scaffolds. Scale bars = 100 μm in (A). Scale bars = 50 μm in (B).
Additional file 4: Figure S4. Gross observations found newly formed
cartilage and well-organized capillary network four weeks after implantation
in the EGFP+Ihh+MSCs/HA group only. Boxed areas (a), (b), and (c) are
shown at higher magnification in (a′), (b′), and (c′), respectively. Implants
were removed from (a′), (b′), and (c′) to show the inner side of defect sites.
New cartilage tissues were observed in the inner side of defect site
((c′), black arrows indicate cartilage tissues). Well-arranged capillary network
showing in figure (c′) (white arrows indicate capillaries).
Additional file 5: Figure S5. Ihh induced CD31 and Oc expression in
C3H10T1/2 cells. (a) Typical images suggested induction of CD31 (red,
bottom panel) by overexpression of Ihh (GFP+) comparing with none
transfected cells (GFP−, green, upper panel), 21 days after gene transfection.
(b) Typical images also demonstrated overexpression of Ihh (GFP+)
upregulated Oc (red, bottom panels), comparing with none transfected cells
(GFP−, green, upper panel), 21 days after gene transfection. Blue in all panels
is DAPI stain. Ihh, EGFP+ Ihh+ C3H10T1/2 cells; Cont, C3H10T1/2 cells. In
both case groups (CD31 and Oc), the upregulation was not limited to GFP+
cells, which suggested that the underlying mechanisms could be non-cell
autonomous. Scale bars = 50 μm.
Additional file 6: Figure S6. RT-PCR also found that overexpression of
Ihh significantly regulated many important differentiation related genes
in C3H10T1/2 cells. Typical gel images showed the gene expression
patterns of differentiation-related genes 14 (14d) and 21 (21d) days after
gene transfection. β-actin served as internal control. Control (cont), C3H10T1/
2 cells transfected with EGFP gene. Ihh, C3H10T1/2 cells transfected with
EGFP and Ihh genes. H2O, negative control. Factors of the hedgehog
pathway (Ptc1, Smo, and Gli1~3), osteogenic or chondrocyte markers
(ColX, ColI, Oc, Aggrecan), vascular cell markers (VEGF, Flk-1, CD31,
aSMA), BMPs, and BMP target (BMP2 and 4, RUNX2) were tested. Note
that many genes are differentially regulated but generally consistent
with previous RT-qPCR data.Competing interests
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